Search

everythinglearnresearchcommunity

for

Search:↓

Combining platelet-rich plasma therapy with low dose oral minoxidil improved hair growth in men with hair loss, with slightly higher satisfaction at the higher minoxidil dose.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Dupilumab effectively reduces alopecia areata symptoms in children with atopic dermatitis.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Low-level light therapy safely improves hair coverage, thickness, and count in androgenetic alopecia patients.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

YH0618 helped reduce skin and nail problems and fatigue in chemotherapy patients.

Using adipose-derived stem cell media with minoxidil may help regrow hair in men with hair loss.

The excimer lamp is a safe and effective treatment for severe alopecia areata.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

Vedistry Amla + Tablets improve hair health and are safe to use.

Virtual healthcare significantly improves quality of life for men with hair loss if they stick to the treatment.

Dutasteride 0.5 mg is safe and effective for long-term use in Korean men with hair loss.

Adding PRP to topical mometasone improves and speeds up alopecia areata treatment.

The document doesn't say if the treatment for hair loss worked.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

The drug combination was safe and showed promise in treating advanced tumors.

Intradermal dutasteride effectively and safely improves hair growth in early-stage androgenetic alopecia.

Upadacitinib improved multiple immune-related conditions in one patient.

Men with early-onset hair loss are less responsive to bromocriptine's heart and metabolism benefits.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Combining systemic steroids and dithranol can effectively regrow hair in severe alopecia areata.

More people are using online platforms for hair loss treatment due to convenience and privacy.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Some treatments for hereditary hair loss are effective but vary in results and side effects; new therapies show promise but need more research.

Two patients with stubborn hair loss grew hair after PDRN injections.